Skip to main content

Pfizer maternal RSV vaccine gets FDA approval

New shot designed to protect babies against leading cause of hospitalization is expected to be available this fall.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.